Asklepios Altona-Department of Urology ( Site 0410)

Hamburg 22763

0 studies enrolling now · 1 studies all time

What they study most

Renal Cell Carcinoma

Studies at this site

• A Study of Adjuvant Intismeran Autogene (V940) and Pembrolizumab in Renal Cell Carcinoma (V940-004). — Running, not enrolling